Literature DB >> 18945764

Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF.

Sarah Mole1, Steven G Milligan, Sheila V Graham.   

Abstract

Human papillomavirus (HPV) gene expression is regulated in concert with the epithelial differentiation program. In particular, expression of the virus capsid proteins L1 and L2 is tightly restricted to differentiated epithelial cells. For HPV16, the capsid proteins are encoded by 13 structurally different mRNAs that are produced by extensive alternative splicing. Previously, we demonstrated that upon epithelial differentiation, HPV16 infection upregulates hnRNP A1 and SF2/ASF, both key factors in alternative splicing regulation. Here we cloned a 1-kb region upstream of and including the transcriptional start site of the SF2ASF gene and used it in in vivo transcription assays to demonstrate that the HPV16 E2 transcription factor transactivates the SF2/ASF promoter. The transactivation domain but not the DNA binding domain of the protein is necessary for this. Active E2 association with the promoter was demonstrated using chromatin immunoprecipitation assays. Electrophoretic mobility shift assays indicated that E2 interacted with a region 482 to 684 bp upstream of the transcription initiation site in vitro. This is the first time that HPV16 E2 has been shown to regulate cellular gene expression and the first report of viral regulation of expression of an RNA processing factor. Such E2-mediated control during differentiation of infected epithelial cells may facilitate late capsid protein expression and completion of the virus life cycle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945764      PMCID: PMC2612322          DOI: 10.1128/JVI.01414-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

Review 1.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

2.  Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions.

Authors:  F Stubenrauch; A M Colbert; L A Laimins
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing.

Authors:  M C Lai; B H Teh; W Y Tarn
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

4.  Expression patterns of the human papillomavirus type 16 transcription factor E2 in low- and high-grade cervical intraepithelial neoplasia.

Authors:  N J Maitland; S Conway; N S Wilkinson; J Ramsdale; J R Morris; C M Sanders; J E Burns; P L Stern; M Wells
Journal:  J Pathol       Date:  1998-11       Impact factor: 7.996

5.  A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein.

Authors:  Xiaomin Zhao; Daniel Oberg; Margaret Rush; Joanna Fay; Helen Lambkin; Stefan Schwartz
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

6.  Specific in vitro interaction between papillomavirus E2 proteins and TBP-associated factors.

Authors:  Elba Carrillo; Efrain Garrido; Patricio Gariglio
Journal:  Intervirology       Date:  2004       Impact factor: 1.763

7.  Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex.

Authors:  C Enzenauer; G Mengus; A Lavigne; I Davidson; H Pfister; M May
Journal:  Intervirology       Date:  1998       Impact factor: 1.763

8.  Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism.

Authors:  R S Hegde; E J Androphy
Journal:  J Mol Biol       Date:  1998-12-18       Impact factor: 5.469

9.  Human papillomavirus type 16 and 18 gene expression in cervical neoplasias.

Authors:  M H Stoler; C R Rhodes; A Whitbeck; S M Wolinsky; L T Chow; T R Broker
Journal:  Hum Pathol       Date:  1992-02       Impact factor: 3.466

10.  Characterization of the human papillomavirus E2 protein: evidence of trans-activation and trans-repression in cervical keratinocytes.

Authors:  V Bouvard; A Storey; D Pim; L Banks
Journal:  EMBO J       Date:  1994-11-15       Impact factor: 11.598

View more
  29 in total

Review 1.  Human Papillomavirus E2 Protein: Linking Replication, Transcription, and RNA Processing.

Authors:  Sheila V Graham
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

2.  Identification and analysis of papillomavirus E2 protein binding sites in the human genome.

Authors:  Liisi Võsa; Aleksander Sudakov; Maido Remm; Mart Ustav; Reet Kurg
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

3.  HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation.

Authors:  Cecilia Johansson; Monika Somberg; Xiaoze Li; Ellenor Backström Winquist; Joanna Fay; Fergus Ryan; David Pim; Lawrence Banks; Stefan Schwartz
Journal:  EMBO J       Date:  2012-05-22       Impact factor: 11.598

4.  Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex.

Authors:  Vaishali R Moulton; George C Tsokos
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

5.  Multiple ASF/SF2 sites in the human papillomavirus type 16 (HPV-16) E4-coding region promote splicing to the most commonly used 3'-splice site on the HPV-16 genome.

Authors:  Monika Somberg; Stefan Schwartz
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

Review 6.  Involvement of Brd4 in different steps of the papillomavirus life cycle.

Authors:  Thomas Iftner; Juliane Haedicke-Jarboui; Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  Virus Res       Date:  2016-12-10       Impact factor: 3.303

Review 7.  Regulation of human papillomavirus gene expression by splicing and polyadenylation.

Authors:  Cecilia Johansson; Stefan Schwartz
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

Review 8.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

Review 9.  Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies.

Authors:  Sheila V Graham
Journal:  Future Microbiol       Date:  2010-10       Impact factor: 3.165

10.  Stochastic modeling of human papillomavirusearly promoter gene regulation.

Authors:  Alberto Giaretta; Gianna Maria Toffolo; Timothy C Elston
Journal:  J Theor Biol       Date:  2019-10-28       Impact factor: 2.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.